Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wyld is a leading consumer health and wellness company specializing in the production of cannabinoid-infused edibles, particularly gummies and sparkling waters. The company distinguishes itself in the crowded CBD and cannabis market through a focus on food science, utilizing real fruit ingredients and consistent dosage formulations. While primarily a consumer-facing brand, Wyld operates at the intersection of food technology and cannabinoid science, maintaining rigorous quality standards and third-party testing for its broad range of CBD, CBG, and CBN products. Their business model focuses on large-scale manufacturing and multi-state distribution across the United States and Canada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wyld.